Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Adma Biologics Inc (ADMA)

354 + Investors. Track Smart Money conviction in ADMA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +1
Streak
1Q ▲
Buyers last Q
52%

Smart Money Signals — ADMA

Based on 355 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added ADMA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (97% of max)

97% of all-time peak
355 hedge funds hold ADMA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +4% more funds vs a year ago

fund count last 6Q
+13 new funds entered over the past year (+4% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 52% buying

204 buying187 selling
Last quarter: 204 funds bought or added vs 187 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+11 vs last Q)

new funds entering per quarter
Funds opening a new ADMA position: 82 → 61 → 60 → 71. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 39% long-term, 23% new

■ 39% conviction (2yr+) ■ 37% medium ■ 23% new
Of the 355 current holders: 140 (39%) held >2 years, 133 held 1–2 years, and 82 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares -2%, value -52%

Value
-52%
Shares
-2%
Last quarter: funds added -2% more shares while total portfolio value only changed -52%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~71 new funds/quarter

68 → 82 → 61 → 60 → 71 new funds/Q
New funds entering each quarter: 82 → 61 → 60 → 71. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 46% veterans vs 31% newcomers

■ 46% veterans ■ 22% 1-2yr ■ 31% new
Entry-cohort mix of 370 holders: 171 (46%) are 2+ year veterans, 83 entered 1–2 years ago, and 116 (31%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 61% AUM from top-100 funds

61% from top-100 AUM funds
56 of 354 holders are among the 100 largest funds by AUM, controlling 61% of total institutional value in ADMA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ADMA

In 2026 Q1, 204 hedge funds were net buyers of ADMA (71 opened a new position, 133 added to an existing one), while 187 reduced or exited (117 trimmed, 70 sold completely) — a 52% buyer ratio, indicating a slight buying edge. 61% of total institutional value in ADMA is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +1 funds (more new holders than closures). Total institutional holders: 355.

Hedge Fund Ownership: ADMA

How many hedge funds hold ADMA — quarterly history vs. share price
Quarterly hedge fund ownership of ADMA vs. share price

Market Analysis: ADMA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ADMA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Adma Biologics Inc (ADMA) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ADMA has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 46d ago
ADMA
+13.1%
XLV
+5.5%

ADMA outperformed XLV by +7.6% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 1d ago
ADMA
+0.0%
XLV
+0.0%

Since the filing became public, ADMA outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

29 top-rated funds 2 high-conviction
Consensus
6.4
/ 10
breadth
×
Elite
3.0
/ 10
conviction
Hedge Fund Positioning: ADMA
2026 Q2 Stats Unlock in 4 days 354 + Investors

Track Smart Money conviction in ADMA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 354 353 0.28%
13F Shares 220M 225M -2.21%
Total Value $1.93B $4.05B -52.33%
New Positions 70 60 +10
Increased Positions 132 143 -11
Closed Positions 69 65 +4
Reduced Positions 110 117 -7
Total Calls 10 9 11.11%
Total Puts 6 8 -25.0%
PUT/CALL Ratio 0.6 0.89 Bullish

Statistics: ADMA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

354 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ADMA. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 ADMA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 B Group, Inc. 12.82% 3,262,542 $27.3M
2 Stonepine Capital Management, LLC 3.72% 650,000 $8.0M
3 Stonepine Capital Management, LLC 2.90% 740,000 $6.2M
4 Caligan Partners LP 2.25% 5,725,007 $47.9M
5 Velan Capital Investment Management LP 1.27% 250,000 $2.1M
6 Ranger Investment Management, L.P. 1.12% 2,115,417 $17.7M
7 Marathon Capital Management 0.90% 532,353 $4.5M
8 Rubric Capital Management LP 0.72% 9,339,414 $78.2M
9 Clearline Capital LP 0.67% 1,334,725 $11.2M
10 Nantahala Capital Management, LLC 0.66% 2,359,993 $19.8M
11 Future Fund LLC 0.60% 248,524 $2.1M
12 Ardsley Advisory Partners LP 0.52% 600,000 $5.0M
13 Virtus Investment Advisers, LLC 0.28% 141,642 $1.2M
14 Kennedy Capital Management LLC 0.26% 1,755,152 $14.7M
15 Diadema Partners LP 0.21% 200,000 $1.7M
16 Odyssean, LLC 0.17% 124,498 $1.0M
17 Kings Path Partners LLC 0.16% 28,940 $424K
18 National Philanthropic Trust 0.14% 1,195,496 $10.0M
19 Boothbay Fund Management, LLC 0.13% 1,176,682 $9.8M
20 Ruffer LLP 0.13% 422,958 $3.5M
21 Caligan Partners LP 0.12% 300,000 $2.5M
22 Fundsmith LLP 0.10% 1,649,493 $13.8M
23 Campbell & CO Investment Adviser LLC 0.10% 224,040 $1.9M
24 Twinbeech Capital LP 0.10% 63,434 $531K
25 Y-Intercept (Hong Kong) Ltd 0.10% 573,581 $4.8M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Adma Biologics Inc (ADMA)

What does the Smart Money Trend signal show for ADMA?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ADMA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ADMA?

Slight buying edge — 52% buying: Last quarter: 204 funds bought or added vs 187 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ADMA holders?

Elite ownership — 61% AUM from top-100 funds: 56 of 354 holders are among the 100 largest funds by AUM, controlling 61% of total institutional value in ADMA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ADMA?

Mixed — 39% long-term, 23% new: Of the 355 current holders: 140 (39%) held >2 years, 133 held 1–2 years, and 82 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Adma Biologics Inc (ADMA) following the 2026 Q2 hedge fund 13F filings?

As of today, ADMA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), ADMA has gained +13.1% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →